The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benoit, L.
Right arrow Articles by Tan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benoit, L.
Right arrow Articles by Tan, R.
The Journal of Immunology, 2000, 165: 3549-3553.
Copyright © 2000 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Defective NK Cell Activation in X-Linked Lymphoproliferative Disease1

Loralyn Benoit*, Xiaoxia Wang*, Henry F. Pabst{ddagger}, Jan Dutz{dagger} and Rusung Tan2,*

Departments of * Pathology and Laboratory Medicine and {dagger} Medicine, University of British Columbia and Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, Canada; {ddagger} Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada; and § Department of Pathology and Laboratory Medicine, British Columbia’s Children’s Hospital, Vancouver, British Columbia, Canada

X-linked lymphoproliferative disease (XLP) is characterized by a selective immune deficiency to EBV. The molecular basis of XLP has been attributed to mutations of signaling lymphocytic activation molecule-associated protein, an intracellular molecule known to associate with the lymphocyte-activating surface receptors SLAM and 2B4. We have identified a single nucleotide mutation in SLAM-associated protein that affects the NK cell function of males carrying the mutated gene. In contrast to normal controls, both NK and lymphokine-activated killer cell cytotoxicity was significantly reduced in two XLP patients. In addition to decreased baseline cytotoxicity, ligation of 2B4 significantly augmented NK lytic function in normal controls but failed to enhance the cytotoxicity of NK cells from XLP patients. These findings suggest that association of SAP with 2B4 is necessary for optimal NK/lymphokine-activated killer cytotoxicity and imply that alterations in SAP/2B4 signaling contribute to the immune dysfunction observed in XLP.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. Iannello, O. Debbeche, S. Samarani, and A. Ahmad
Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS
J. Leukoc. Biol., July 1, 2008; 84(1): 1 - 26.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. K. Chlewicki, C. A. Velikovsky, V. Balakrishnan, R. A. Mariuzza, and V. Kumar
Molecular Basis of the Dual Functions of 2B4 (CD244)
J. Immunol., June 15, 2008; 180(12): 8159 - 8167.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. Y. Pappworth, E. C. Wang, and M. Rowe
The Switch from Latent to Productive Infection in Epstein-Barr Virus-Infected B Cells Is Associated with Sensitization to NK Cell Killing
J. Virol., January 15, 2007; 81(2): 474 - 482.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Vacca, G. Pietra, M. Falco, E. Romeo, C. Bottino, F. Bellora, F. Prefumo, E. Fulcheri, P. L. Venturini, M. Costa, et al.
Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function
Blood, December 15, 2006; 108(13): 4078 - 4085.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
S Mori, M-C Zhang, N Tanda, F Date, M Nose, H Furukawa, and M Ono
Genetic characterisation of spontaneous ankylosing arthropathy with unique inheritance from Fas-deficient strains of mice
Ann Rheum Dis, October 1, 2006; 65(10): 1273 - 1278.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Gu, S. G. Tangye, X. Sun, Y. Luo, Z. Lin, and J. Wu
The X-linked lymphoproliferative disease gene product SAP associates with PAK-interacting exchange factor and participates in T cell activation
PNAS, September 26, 2006; 103(39): 14447 - 14452.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. Bhat, P. Eissmann, J. Endt, S. Hoffmann, and C. Watzl
Fine-tuning of immune responses by SLAM-related receptors
J. Leukoc. Biol., March 1, 2006; 79(3): 417 - 424.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Gao, P. Schwartzberg, J. A. Wilder, B. R. Blazar, and D. Yuan
B Cell Induction of IL-13 Expression in NK Cells: Role of CD244 and SLAM-Associated Protein.
J. Immunol., March 1, 2006; 176(5): 2758 - 2764.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Komori, H. Furukawa, S. Mori, M. R. Ito, M. Terada, M.-C. Zhang, N. Ishii, N. Sakuma, M. Nose, and M. Ono
A Signal Adaptor SLAM-Associated Protein Regulates Spontaneous Autoimmunity and Fas-Dependent Lymphoproliferation in MRL-Faslpr Lupus Mice
J. Immunol., January 1, 2006; 176(1): 395 - 400.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Tassi and M. Colonna
The Cytotoxicity Receptor CRACC (CS-1) Recruits EAT-2 and Activates the PI3K and Phospholipase C{gamma} Signaling Pathways in Human NK Cells
J. Immunol., December 15, 2005; 175(12): 7996 - 8002.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Saborit-Villarroya, J. M. Del Valle, X. Romero, E. Esplugues, P. Lauzurica, P. Engel, and M. Martin
The Adaptor Protein 3BP2 Binds Human CD244 and Links this Receptor to Vav Signaling, ERK Activation, and NK Cell Killing
J. Immunol., October 1, 2005; 175(7): 4226 - 4235.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Morandi, R. Costa, M. Falco, S. Parolini, A. De Maria, G. Ratto, M. C. Mingari, G. Melioli, A. Moretta, and G. Ferlazzo
Distinctive Lack of CD48 Expression in Subsets of Human Dendritic Cells Tunes NK Cell Activation
J. Immunol., September 15, 2005; 175(6): 3690 - 3697.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Assarsson, T. Kambayashi, C. M. Persson, B. J. Chambers, and H.-G. Ljunggren
2B4/CD48-Mediated Regulation of Lymphocyte Activation and Function
J. Immunol., August 15, 2005; 175(4): 2045 - 2049.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. O. Mathew, P. R. Kumaresan, J. K. Lee, V. T. Huynh, and P. A. Mathew
Mutational Analysis of the Human 2B4 (CD244)/CD48 Interaction: Lys68 and Glu70 in the V Domain of 2B4 Are Critical for CD48 Binding and Functional Activation of NK Cells
J. Immunol., July 15, 2005; 175(2): 1005 - 1013.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Eissmann, L. Beauchamp, J. Wooters, J. C. Tilton, E. O. Long, and C. Watzl
Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244)
Blood, June 15, 2005; 105(12): 4722 - 4729.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Aoukaty and R. Tan
Role for Glycogen Synthase Kinase-3 in NK Cell Cytotoxicity and X-Linked Lymphoproliferative Disease
J. Immunol., April 15, 2005; 174(8): 4551 - 4558.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Chung, A. Aoukaty, J. Dutz, C. Terhorst, and R. Tan
Cutting Edge: Signaling Lymphocytic Activation Molecule-Associated Protein Controls NKT Cell Functions
J. Immunol., March 15, 2005; 174(6): 3153 - 3157.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. V. Vaidya, S. E. Stepp, M. E. McNerney, J.-K. Lee, M. Bennett, K.-M. Lee, C. L. Stewart, V. Kumar, and P. A. Mathew
Targeted Disruption of the 2B4 Gene in Mice Reveals an In Vivo Role of 2B4 (CD244) in the Rejection of B16 Melanoma Cells
J. Immunol., January 15, 2005; 174(2): 800 - 807.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Mooney, J. Klem, C. Wulfing, L. A. Mijares, P. L. Schwartzberg, M. Bennett, and J. D. Schatzle
The Murine NK Receptor 2B4 (CD244) Exhibits Inhibitory Function Independent of Signaling Lymphocytic Activation Molecule-Associated Protein Expression
J. Immunol., September 15, 2004; 173(6): 3953 - 3961.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Chen, F. Relouzat, R. Roncagalli, A. Aoukaty, R. Tan, S. Latour, and A. Veillette
Molecular Dissection of 2B4 Signaling: Implications for Signal Transduction by SLAM-Related Receptors
Mol. Cell. Biol., June 15, 2004; 24(12): 5144 - 5156.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. Veillette
SLAM Family Receptors Regulate Immunity with and without SAP-related Adaptors
J. Exp. Med., May 3, 2004; 199(9): 1175 - 1178.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
K.-M. Lee, M. E. McNerney, S. E. Stepp, P. A. Mathew, J. D. Schatzle, M. Bennett, and V. Kumar
2B4 Acts As a Non-Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells
J. Exp. Med., May 3, 2004; 199(9): 1245 - 1254.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Simarro, A. Lanyi, D. Howie, F. Poy, J. Bruggeman, M. Choi, J. Sumegi, M. J. Eck, and C. Terhorst
SAP increases FynT kinase activity and is required for phosphorylation of SLAM and Ly9
Int. Immunol., May 1, 2004; 16(5): 727 - 736.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Li, C. Iosef, C. Y. H. Jia, V. K. M. Han, and S. S.-C. Li
Dual Functional Roles for the X-linked Lymphoproliferative Syndrome Gene Product SAP/SH2D1A in Signaling through the Signaling Lymphocyte Activation Molecule (SLAM) Family of Immune Receptors
J. Biol. Chem., January 31, 2003; 278(6): 3852 - 3859.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. Watzl and E. O. Long
Natural Killer Cell Inhibitory Receptors Block Actin Cytoskeleton-dependent Recruitment of 2B4 (CD244) to Lipid Rafts
J. Exp. Med., January 6, 2003; 197(1): 77 - 85.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. D. Arkwright, M. Abinun, and A. J. Cant
Autoimmunity in human primary immunodeficiency diseases
Blood, April 15, 2002; 99(8): 2694 - 2702.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Aoukaty and R. Tan
Association of the X-linked Lymphoproliferative Disease Gene Product SAP/SH2D1A with 2B4, a Natural Killer Cell-activating Molecule, Is Dependent on Phosphoinositide 3-Kinase
J. Biol. Chem., April 5, 2002; 277(15): 13331 - 13337.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. S. Chuang, P. R. Kumaresan, and P. A. Mathew
2B4 (CD244)-Mediated Activation of Cytotoxicity and IFN-{gamma} Release in Human NK Cells Involves Distinct Pathways
J. Immunol., December 1, 2001; 167(11): 6210 - 6216.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Bouchon, M. Cella, H. L. Grierson, J. I. Cohen, and M. Colonna
Cutting Edge: Activation of NK Cell-Mediated Cytotoxicity by a SAP-Independent Receptor of the CD2 Family
J. Immunol., November 15, 2001; 167(10): 5517 - 5521.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Nakamura, J. Zarycki, J. L. Sullivan, and J. U. Jung
Abnormal T Cell Receptor Signal Transduction of CD4 Th Cells in X-Linked Lymphoproliferative Syndrome
J. Immunol., September 1, 2001; 167(5): 2657 - 2665.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Morra, O. Silander, S. Calpe, M. Choi, H. Oettgen, L. Myers, A. Etzioni, R. Buckley, and C. Terhorst
Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome
Blood, September 1, 2001; 98(5): 1321 - 1325.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Czar, E. N. Kersh, L. A. Mijares, G. Lanier, J. Lewis, G. Yap, A. Chen, A. Sher, C. S. Duckett, R. Ahmed, et al.
Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP
PNAS, June 7, 2001; (2001) 131193098.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. S. Chuang, H.-T. K. Pham, P. R. Kumaresan, and P. A. Mathew
A Prominent Role for Activator Protein-1 in the Transcription of the Human 2B4 (CD244) Gene in NK Cells
J. Immunol., May 15, 2001; 166(10): 6188 - 6195.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. P. Dutz, L. Benoit, X. Wang, D. J. Demetrick, A. Junker, D. de Sa, and R. Tan
Lymphocytic vasculitis in X-linked lymphoproliferative disease
Blood, January 1, 2001; 97(1): 95 - 100.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Morra, M. Simarro-Grande, M. Martin, A. S.-I. Chen, A. Lanyi, O. Silander, S. Calpe, J. Davis, T. Pawson, M. J. Eck, et al.
Characterization of SH2D1A Missense Mutations Identified in X-linked Lymphoproliferative Disease Patients
J. Biol. Chem., September 21, 2001; 276(39): 36809 - 36816.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Czar, E. N. Kersh, L. A. Mijares, G. Lanier, J. Lewis, G. Yap, A. Chen, A. Sher, C. S. Duckett, R. Ahmed, et al.
Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP
PNAS, June 19, 2001; 98(13): 7449 - 7454.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.